Profile data is unavailable for this security.
About the company
Hua Medicine is an investment holding company primarily engaged in the development and commercialization of oral drug for the treatment of Type 2 diabetes. The Company is also engaged in the commercialization of HuaTangNing products. The Company’s main product pipeline dorzagliatin or HMS5552 is a glucokinase activator or GKA, designed to control the progressive degenerative nature of diabetes by restoring glucose homeostasis in Type 2 diabetes. The Company mainly conducts its businesses in the domestic market.
- Revenue in HKD (TTM)419.33m
- Net income in HKD1.22bn
- Incorporated2009
- Employees285.00
- LocationHua MedicineHua Medicine, 275 Ai Di Sheng RoadSHANGHAI 201203ChinaCHN
- Phone+86 2 158869997
- Websitehttps://www.huamedicine.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cloudbreak Pharma Inc | 78.15m | -326.93m | 1.92bn | 60.00 | -- | -- | -- | 24.58 | -0.3897 | -0.3897 | 0.0932 | -3.08 | -- | -- | -- | 1,532,373.00 | -- | -- | -- | -- | -- | -- | -418.33 | -- | -- | -- | 19.44 | -- | -- | -- | 23.40 | -- | -- | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | 126.82m | -342.43m | 1.96bn | 195.00 | -- | 3.06 | -- | 15.48 | -0.8705 | -0.8705 | 0.3221 | 1.48 | 0.148 | -- | 3,865.48 | 812,941.60 | -40.09 | -- | -51.56 | -- | -- | -- | -270.79 | -- | -- | -- | 0.2236 | -- | 19,109.59 | -- | 16.76 | -- | -- | -- |
| Mabpharm Ltd | 479.59m | -31.09m | 2.10bn | 383.00 | -- | 18.81 | 57.03 | 4.39 | -0.0076 | -0.0076 | 0.1163 | 0.0271 | 0.4209 | 0.4659 | 4.05 | 1,522,523.00 | -2.73 | -19.62 | -4.02 | -25.69 | 86.40 | -- | -6.48 | -211.59 | 0.6906 | -1.58 | 0.7552 | -- | 196.27 | -- | 38.89 | -- | -12.13 | -- |
| Jiangsu Recbio Technology Co Ltd | 12.33m | -739.77m | 2.17bn | 507.00 | -- | 10.61 | -- | 176.26 | -1.55 | -1.55 | 0.0258 | 0.4242 | 0.006 | -- | -- | 23,220.65 | -36.26 | -31.31 | -64.03 | -37.31 | -- | -- | -5,990.59 | -- | 0.2767 | -100.74 | 0.8254 | -- | -- | -- | 1.67 | -- | 16.82 | -- |
| Frontage Holdings Corp | 1.98bn | 29.97m | 2.20bn | 1.54k | 73.12 | 0.8238 | 6.99 | 1.11 | 0.0148 | 0.0148 | 0.9735 | 1.31 | 0.4545 | 60.36 | 3.97 | 1,267,499.00 | 0.6902 | 3.05 | 0.8654 | 3.64 | 27.78 | 32.14 | 1.52 | 6.84 | 1.22 | 1.97 | 0.2861 | 0.00 | -1.90 | 20.48 | -92.68 | -46.72 | 13.29 | -- |
| Antengene Corp Ltd | 95.43m | -258.61m | 2.34bn | 152.00 | -- | 2.70 | -- | 24.56 | -0.4162 | -0.4162 | 0.1536 | 1.28 | 0.0619 | 1.51 | 3.20 | 564,671.80 | -16.77 | -48.14 | -19.52 | -53.06 | 78.54 | -- | -271.00 | -1,460.93 | 4.41 | -- | 0.2346 | -- | 36.62 | -- | 45.07 | -- | 259.46 | -- |
| Hanx Biopharmaceuticals (Wuhan) Co Ltd | -100.00bn | -100.00bn | 2.62bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -52.30 | -- | -- | -- |
| Clover Biopharmaceuticals Ltd | 58.57m | -1.03bn | 2.86bn | 243.00 | -- | -- | -- | 48.76 | -0.8194 | -0.8194 | 0.0466 | -1.49 | 0.0433 | 0.0547 | 47.89 | 195,238.00 | -76.07 | -75.37 | -- | -188.14 | 62.57 | -- | -1,756.85 | -13,419.00 | 0.2541 | -- | -- | -- | -2.13 | -- | -552.11 | -- | -24.90 | -- |
| BioDlink International Co Ltd | 1.21bn | 8.21m | 3.25bn | 604.00 | 370.88 | 3.92 | 35.55 | 2.69 | 0.0113 | 0.0113 | 1.66 | 1.07 | 0.7275 | 2.35 | 5.49 | 1,975,381.00 | 0.495 | -11.37 | 0.6586 | -14.89 | 71.10 | 73.14 | 0.6805 | -24.91 | 1.68 | 1.83 | 0.3519 | -- | 40.70 | 89.20 | 192.05 | -- | 27.04 | -- |
| Hua Medicine | 419.33m | 1.22bn | 3.30bn | 285.00 | 2.55 | 2.56 | 2.62 | 7.86 | 1.23 | 1.23 | 0.4248 | 1.22 | 0.2411 | 1.76 | 5.71 | 2,496,030.00 | 69.99 | -21.83 | 82.64 | -25.31 | 52.55 | -- | 290.30 | -395.24 | 7.00 | -- | 0.2038 | -- | 234.02 | -- | -18.42 | -- | -17.81 | -- |
| Medtide Inc | -100.00bn | -100.00bn | 3.61bn | 520.00 | -- | 2.17 | -- | -- | -- | -- | -- | 11.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 4.48 | -- | 0.0335 | -- | 31.31 | -- | 21.00 | -- | -- | -- |
| Visen Pharmaceuticals | -100.00bn | -100.00bn | 3.88bn | 54.00 | -- | 3.70 | -- | -- | -- | -- | -- | 9.22 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0014 | -- | -- | -- | 26.98 | -- | -- | -- |
| Qyuns Therapeutics Co Ltd | 362.43m | -216.98m | 4.61bn | 337.00 | -- | 17.79 | -- | 12.71 | -0.9769 | -0.9769 | 1.63 | 1.15 | 0.2903 | 4.05 | 9.14 | 1,069,106.00 | -17.90 | -- | -28.45 | -- | 72.44 | -- | -61.64 | -- | 1.43 | -23.19 | 0.7466 | -- | -- | -- | 33.91 | -- | -- | -- |
| Jacobio Pharmaceuticals Group Co Ltd | 227.81m | -51.64m | 4.80bn | 211.00 | -- | 4.90 | -- | 21.06 | -0.0667 | -0.0667 | 0.2945 | 1.24 | 0.1547 | -- | 7.97 | 886,437.60 | -3.51 | -36.09 | -4.01 | -39.58 | 100.00 | 65.67 | -22.67 | -283.16 | -- | -- | 0.1415 | -- | 145.13 | -- | 56.64 | -- | 29.33 | -- |
| TYK Medicines Inc | 121.05k | -316.86m | 4.85bn | 163.00 | -- | 11.72 | -- | 40,063.00 | -0.8545 | -0.8545 | 0.0003 | 1.09 | 0.0002 | -- | -- | 791.18 | -42.68 | -- | -- | -- | 13.08 | -- | -263,981.30 | -- | -- | -- | 0.3215 | -- | -- | -- | -1.18 | -- | -- | -- |
Data as of Feb 16 2026. Currency figures normalised to Hua Medicine's reporting currency: Hong Kong Dollar HKD
1.78%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| JPMorgan Asset Management (China) Co Ltd.as of 30 Jun 2025 | 6.41m | 0.61% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 3.99m | 0.38% |
| First Trust Advisors LPas of 06 Feb 2026 | 3.66m | 0.35% |
| SSgA Funds Management, Inc.as of 05 Feb 2026 | 2.45m | 0.23% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 1.10m | 0.10% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 600.00k | 0.06% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 313.50k | 0.03% |
| Truvalue Asset Management Co. Ltd.as of 30 Jun 2025 | 183.00k | 0.02% |
| Connor, Clark & Lunn Investment Management Ltd.as of 30 Jan 2026 | 45.00k | 0.00% |
| DFA Australia Ltd.as of 31 Dec 2025 | 41.46k | 0.00% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
